Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI)
- PMID: 1774603
- DOI: 10.1002/jcla.1860050606
Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI)
Abstract
Circulating HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor were measured in 13 zidovudine-intolerant patients (8 with ARC and 5 with AIDS) treated with dideoxyinosine (ddI). Measurements were made at baseline and at several intervals during therapy. Mean levels of HIV P24 antigen decreased early and significantly (P less than 0.01) after 2 weeks of ddI administration and remained low at weeks 8 and 12. In addition, mean SCD8 levels decreased late and significantly (P less than 0.02) after 16 weeks of ddI treatment and remained low at 24 weeks. In contrast, ddI administration had no substantial effect on mean levels of beta 2-microglobulin, neopterin, soluble CD4, and soluble interleukin-2 receptor. ddI administration appears to have been associated with early reduction of HIV P24 antigen levels and later reduction of SCD8 mean levels in these patients.
Similar articles
-
Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.Int J Immunopharmacol. 1990;12(7):737-41. doi: 10.1016/0192-0561(90)90036-m. Int J Immunopharmacol. 1990. PMID: 2127261 Clinical Trial.
-
Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.AIDS. 1993 Mar;7(3):369-73. doi: 10.1097/00002030-199303000-00010. AIDS. 1993. PMID: 8097095
-
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.BMJ. 1991 Jan 12;302(6768):73-8. doi: 10.1136/bmj.302.6768.73. BMJ. 1991. PMID: 1671651 Free PMC article.
-
Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.Infection. 1991;19 Suppl 2:S98-102. doi: 10.1007/BF01644476. Infection. 1991. PMID: 1673120 Review.
-
Didanosine.Ann Pharmacother. 1992 May;26(5):660-70. doi: 10.1177/106002809202600511. Ann Pharmacother. 1992. PMID: 1350471 Review.
Cited by
-
Clinical efficacy of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine (PMPDAP) in the treatment of feline immunodeficiency virus-infected cats.J Feline Med Surg. 2012 Feb;14(2):107-12. doi: 10.1177/1098612X11431040. J Feline Med Surg. 2012. PMID: 22314085 Free PMC article. Clinical Trial.
-
Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.Clin Pharmacokinet. 1995 Jul;29(1):46-65. doi: 10.2165/00003088-199529010-00006. Clin Pharmacokinet. 1995. PMID: 7586898 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials